Researchers will dose participants with psilocybin while they receive psychological support. The firm hopes more countries will join the project as and when respective health bodies approve the use of psilocybin for clinical trials. “If our studies are successful, we could be applying for marketing authorization in two to three years,” she said, describing depression as “a…
Findings from a study presented at the annual convention of the American Psychological Association suggested that symptoms of social anxiety in autistic adults may be treatable with a combination of psychotherapy and MDMA … Research discussed also explored how LSD, psilocybin (known colloquially as “magic mushrooms”) and ayahuasca (a brew used by indigenous people of the…
Throughout the symposium presenters discussed need for additional research to gain better understandings of the implications of using such psychedelics as an adjunct to psychotherapy as well as legal and ethical issues needing to be considered. Traditionally psychedelics drugs are thought of as relics from hippie generations or taken by music festival and rave goers,…
The government’s data has previously failed to make a compelling argument that kratom actually kills people, and the new cases don’t offer much support… [Jane Babin, an attorney and molecular biologist who’s been investigating kratom death reports.] expressed concern [however] that confusion [and misleading news reports are] leading health officials to blame kratom for any death where mitragynine…
Dr. Williams wondered if the drug could be helpful for black and brown people suffering from PTSD. She notes how the most currently accepted treatment — prolonged exposure (PE) — can be difficult for many patients, and especially for racial or demographic minorities. Even in the field of psychedelic research, her study stands out as…
Last August 2017, the agency streamlined that process by deeming MDMA a “breakthrough therapy,” meaning it “may demonstrate substantial improvement” over current options. MDMA, which was banned by the Drug Enforcement Administration in 1985, could be available by prescription as soon as 2021. The rehabilitation of MDMA, a.k.a. “ecstasy” or “molly,” is directly related to…
In a recent update of its official position on the botanical kratom, the National Institute of Drug Abuse (NIDA) affirmed that, “Kratom by itself is not associated with fatal overdose,” explaining that only when the natural ingredient is contaminated or “laced with other compounds” has it been associated with death. NIDA’s position clarifies and corrects an earlier statement…
The recently released Hemby study : https://onlinelibrary.wiley.com/doi/10.1111/adb.12639 published in Addiction Biology sent shock waves through the FDA corridors with the finding that mitragynine, the major alkaloid in kratom, “does not have an abuse potential and reduces morphine intake” which is exactly the pharmacologic activity for “candidate pharmacotherapies for opiate addiction and withdrawal.” This study directly challenges the…
Working backwards, they discovered that psychedelic-users were not at an increased risk of developing eleven key indicators of serious mental health problems. A second study done at the University of Alabama and Johns Hopkins confirmed this finding. This study used the National Survey as core data, but examined responses from 2008 to 2012. Here too,…
The U.S. Food and Drug Administration (FDA) has denied a request from an anti-legalization group to place marijuana and its derivatives on a list of restricted substances that are not “generally recognized as safe and effective.” The organization had filed its petition requesting the cannabis crackdown in December 2017, writing that the move would “send…
Recent Comments